Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-18, Stock:LLY, The news for the past five days is as follows:
2019-04-11: NEWS1: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS2: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS3: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS4: The Zacks Analyst Blog Highlights: Eli Lilly, Altria, Becton, Dickinson, T-Mobile and General Motors.NEWS5: The Zacks Analyst Blog Highlights: Eli Lilly, Altria, Becton, Dickinson, T-Mobile and General Motors.NEWS6: Eli Lilly Stock Was Downgraded Because Everyone Already Knows It’s Good.NEWS7: The Zacks Analyst Blog Highlights: Eli Lilly, Altria, Becton, Dickinson, T-Mobile and General Motors.NEWS8: Here are the biggest analyst calls of the day: Apple, Chipotle, IBM, Xerox, U.S. Steel & more.NEWS9: Here are the biggest analyst calls of the day: Apple, Chipotle, IBM, Xerox, U.S. Steel & more.NEWS10: Algorithms, Derivatives and Manias- A Day of Reckoning.
2019-04-12: NEWS1: ACWI, LLY, ABBV, ACN: ETF Inflow Alert.NEWS2: ACWI, LLY, ABBV, ACN: ETF Inflow Alert.
2019-04-15: NEWS1: J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer.NEWS2: J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer.NEWS3: J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer.
2019-04-16: NEWS1: Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales.NEWS2: Technician lays out the best bets in biotech.
2019-04-17: NEWS1: Notable Wednesday Option Activity: TNDM, VRTX, LLY.NEWS2: Notable Wednesday Option Activity: TNDM, VRTX, LLY.NEWS3: Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales.NEWS4: Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales.

Answer: Decrease